Hyperion Defi, Inc. (HYPD): Total Assets
$51.76M
As of 2025-12-31
$113.14M
As of 2026-06-30
+18.6%
3-year compound annual growth
+8.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.76M | n/m | 2026-03-30, Balance as of period end |
| 2024-12-31 | $3.67M | -87.3% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $28.78M | -7.3% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $31.04M | -2.0% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $31.66M | -6.6% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $33.91M | +130.7% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $14.70M | -26.6% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $20.02M | +254.7% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $5.64M | +64.4% | 2019-03-27, Balance as of period end |
| 2016-12-31 | $3.43M | n/a | 2018-04-02, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Hyperion Defi, Inc. (HYPD) | 2025-12-31 | $51.76M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
Compare HYPD, ONCO, RLYB, RFL side by side · Screen every company in Pharmaceutical Preparations ↗